| Year ended 31 December | |||
| 2023 | 2022 | ||
Continuing operations | Note | US$’000 | US$’000 |
Revenue | 4 | ||
Cost of sales | ( | ( | |
Gross profit | |||
Research and development expenses | 5 | ( | ( |
Sales and marketing expenses | ( | ( | |
General and administration expenses | ( | ( | |
of which expected credit loss | 24 | ( | ( |
Other operating (expense)/income | 6 | ( | |
Operating (loss)/profit | ( | ||
Finance income | 9 | ||
Finance expense | 9 | ( | ( |
Loss from joint venture | 16 | ( | ( |
(Loss)/profit before tax | ( | ||
Income tax expense | 10 | ( | ( |
Net (loss) | ( | ( | |
| Other comprehensive income/(expense) | |||
| Items that may be reclassified subsequently to profit or loss: | |||
Currency exchange gain/(loss) on translation of foreign operations | ( | ||
( | |||
| Items that will not be reclassified to profit or loss: | |||
Currency exchange remeasurements of defined benefit obligation | 25 | ( | |
Related income tax credit | |||
( | |||
Other comprehensive income/(expense) | ( | ||
Total comprehensive loss | ( | ( | |
Loss per share (US$ cents) | 11 | ||
Basic | ( | ( | |
Diluted | ( | ( |
| As at 31 December | |||
| Restated | |||
| 2023 | 2022 | ||
| Note | US$’000 | US$’000 | |
| Assets | |||
Cash and cash equivalents | 17 | ||
Trade and other receivables | 18 | ||
Contract assets | 4 | ||
Inventories | 19 | ||
Income tax receivables | |||
Other current assets | 20 | ||
Total current assets | |||
Goodwill | 12 | ||
Other intangible assets | 13 | ||
Property and equipment – owned | 14 | ||
Property and equipment – leased | 15 | ||
Other investments | |||
Trade and other receivables | 18 | ||
Deferred tax assets | 10 | ||
Total non-current assets | |||
Total assets | |||
| Liabilities and equity | |||
Trade and other payables | 21 | ||
Contract liabilities | 4 | ||
Income taxes payable | |||
Lease liabilities | 15 | ||
Loans and borrowings | 22 | ||
Total current liabilities | |||
Trade and other payables | 21 | ||
Lease liabilities | 15 | ||
Loans and borrowings | 22 | ||
Deferred tax liabilities | 10 | ||
Total non-current liabilities | |||
Total liabilities | |||
Ordinary shares | 26 | ||
Share premium account | 26 | ||
Merger reserve | 26 | ( | ( |
Share-based payment reserve | 26 | ||
Currency translation reserve | 26 | ( | ( |
Retained earnings | |||
Total equity | |||
Total liabilities and equity |
| Year ended 31 December | |||
| Restated | |||
| 2023 | 2022 | ||
| Note | US$’000 | US$’000 | |
| Cash flows from operating activities | |||
Net (loss) | ( | ( | |
| Non-cash items within operating profit: | |||
– Amortisation of intangible assets | 13 | ||
– Depreciation of property and equipment – owned | 14 | ||
– Depreciation of property and equipment – leased | 15 | ||
– Share-based compensation expense | 27 | ||
– Currency translation loss/(gain) on intercompany balances | ( | ||
Deferred cash rights | |||
Other income | |||
Finance income | 9 | ( | ( |
Finance expense | 9 | ||
Loss from joint venture | 16 | ||
Income tax expense | |||
Cash generated from operations before changes in working capital | |||
| Changes in working capital: | |||
(Increase) in trade and other receivables | ( | ( | |
Decrease/(increase) in inventories | ( | ||
(Increase) in contract assets | ( | ( | |
Increase in trade and other payables | |||
(Decrease)/increase in contract liabilities | ( | ||
Cash generated from operations | |||
Income taxes paid | ( | ( | |
Cash inflow/(outflow) from operating activities | ( | ||
| Cash flows from investing activities | |||
Purchase of intangible assets | 13 | ( | ( |
Purchase of property and equipment | 14 | ( | ( |
Capitalised development expenditure | ( | ( | |
Investment in joint venture | 16 | ( | ( |
Purchase of businesses, net of acquired cash | ( | ( | |
Interest received | |||
Cash outflow from investing activities | ( | ( | |
| Cash flows from financing activities | |||
Issue of ordinary shares | 26 | ||
Interest paid | ( | ( | |
Lease payments | 15 | ( | ( |
Drawdown of loans and borrowings | |||
Repayment of loans and borrowings | ( | ( | |
Cash (outflow)/inflow from financing activities | ( | ||
Net decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at the beginning of the year | |||
Currency translation gain/(loss) on cash and cash equivalents | ( | ||
Cash and cash equivalents at the end of the year | 17 |
| Ordinary | Share | Share-based | Currency | ||||||
| share | premium | Merger | payment | translation | Retained | ||||
| capital | account | reserve | reserve | reserve | earnings | Total | |||
| Note | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | ||
As at 1 January 2022 | ( | ( | |||||||
| Net loss | ( | ( | |||||||
| Other comprehensive expense | ( | ( | |||||||
| Total comprehensive loss | ( | ( | ( | ||||||
| Settlement of share awards: | |||||||||
– | Issue of ordinary shares | 26 | ( | ||||||
– | Transfer of cumulative | ||||||||
| compensation expense on | |||||||||
settledawards | 27 | ( | |||||||
| Share-based compensation expense | |||||||||
for the year | 27 | ||||||||
| Other changes in equity | |||||||||
| As at 31 December 2022 | ( | ( | |||||||
| Net loss for the year | ( | ( | |||||||
| Other comprehensive expense | ( | ||||||||
Total comprehensive loss for the year | ( | ( | |||||||
| Settlement of share awards: | |||||||||
– | Issue of ordinary shares | 26 | |||||||
– | Transfer of cumulative | ||||||||
| compensation expense on | |||||||||
settledawards | 27 | ( | |||||||
| Share-based compensation expense | |||||||||
for the year | 27 | ||||||||
| Other changes in equity | |||||||||
As at 31 December 2023 | ( | ( | |||||||
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Revenue by type: | ||
IP and NRE | 100,676 | 76,123 |
IP and NRE – Reseller | — | 3,270 |
IP and NRE – JV | 66,891 | 58,207 |
Silicon and royalties | 154,157 | 47,806 |
321,724 | 185,406 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Revenue by region: | ||
North America | 82,160 | 51,361 |
China | 190,376 | 104,755 |
APAC (ex-China) | 33,459 | 16,980 |
EMEA | 15,729 | 12,310 |
321,724 | 185,406 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
China based customer | 78,226 | 34,538 |
China based customer | 66,891 | 58,207 |
| Year ended 31 December | ||
| Restated | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
At the beginning of the year | 58,534 | 31,719 |
Acquisition of subsidiaries | — | 2,714 |
Revenue accrued in the period | 61,182 | 56,231 |
Accrued revenue invoiced in the period | (50,681) | (31,983) |
Expected credit loss | (3,862) | (1,547) |
Currency translation differences | — | (147) |
At the end of the year | 65,173 | 56,987 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
At the beginning of the year | 91,733 | 12,661 |
Acquisition of subsidiaries | — | 41,361 |
Revenue recognised in the period | (90,346) | (38,959) |
Revenue deferred in the period | 48,743 | 76,205 |
Currency translation differences | (24) | 465 |
At the end of the year | 50,106 | 91,733 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Capitalised contract costs | 1,920 | 874 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Research and development costs incurred | 131,441 | 78,011 |
Research and development expenditure credits | (6,999) | (5,198) |
| Development costs capitalised | (46,226) | (3,455) |
Total | 78,216 | 69,358 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Acquisition-related costs | (831) | (12,712) |
Compensation element of Banias Labs deferred cash rights (note 30) | (8,352) | (1,703) |
Remeasurement of contingent consideration payable for Precise-ITC (note 30) | — | (4,260) |
Share-based compensation expense (note 27) | (40,691) | (15,695) |
Currency translation (loss)/gain | (2,983) | 36,838 |
Other operating (expense)/income | (52,857) | 2,468 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Wages and salaries | 84,784 | 45,301 |
Social security costs | 2,033 | 3,959 |
Defined contribution pension costs | 4,115 | 1,300 |
Share-based compensation expense | 40,691 | 15,695 |
Total | 131,623 | 66,255 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| Number | Number | |
Research and development/engineering | 675 | 321 |
General and administration | 55 | 29 |
Sales and marketing | 28 | 11 |
Total | 758 | 361 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| Number | Number | |
Research and development/engineering | 741 | 621 |
General and administration | 58 | 57 |
Sales and marketing | 30 | 17 |
Total | 829 | 695 |
| 8 Auditor’s remuneration |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Audit of the financial statements | 3,472 | 1,713 |
Audit-related assurance services | 268 | 124 |
3,740 | 1,837 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Finance income | ||
Interest income from contracts with customers containing significant financing components | 275 | 235 |
Interest on bank deposits | 3,173 | 1,449 |
3,448 | 1,684 | |
| Finance expense | ||
Bank charges | (65) | — |
Lease interest | (1,581) | (391) |
Term loan interest | (16,489) | (3,134) |
Term loan interest capitalised to the balance sheet | 9,534 | |
NPV interest | – | (27) |
Interest under IAS 19 | (61) | — |
IIA interest | (174) | (36) |
(8,836) | (3,588) | |
Net finance expense | (5,388) | (1,904) |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Current tax | ||
UK corporation tax | (2,642) | 5,792 |
Adjustments to prior periods | 3,167 | (516) |
Overseas tax | 126 | 13,330 |
Total current tax | 651 | 18,606 |
| Deferred tax | ||
Origination and reversal of timing differences | 10,881 | (278) |
Total deferred tax | 10,881 | (278) |
Income tax expense | 11,532 | 18,328 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
(Loss)/profit before tax | (39,470) | 17,242 |
(Loss)/profit before tax at the UK corporation tax rate of 23.52% (2022: 19%) | (9,283) | 3,275 |
| Effects of: | ||
Share-based compensation | 7,267 | 3,141 |
Expenses not deductible for tax purposes | 3,171 | 1,964 |
Under/(over) accrual of prior year provision | 3,167 | (516) |
Different tax rates applied in overseas jurisdictions | 667 | 3,469 |
Share of joint venture’s loss | 3,465 | 3,511 |
Movement in unrecognised deferred tax assets | 2,146 | 3,281 |
Other tax items | 932 | 203 |
Income tax expense | 11,532 | 18,328 |
| Year ended 31 December | ||
| Restated | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
At the beginning of the year | 11,110 | 422 |
Purchase of businesses | – | 15,234 |
Charge/(credit) to profit or loss | 10,881 | (278) |
(Credit) to OCI | (409) | — |
Transfer of tax credits | – | (4,350) |
Currency translation differences | (2) | 82 |
Other | (721) | — |
At the end of the year | 20,859 | 11,110 |
| Year ended 31 December | ||
| Restated | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Accelerated capital allowances | 5,720 | 676 |
Leases | (334) | (65) |
Intangibles | 22,429 | 26,947 |
Non-capital loss | (7,193) | (13,613) |
Transfer of tax credits | – | (4,350) |
Other temporary differences | 237 | 1,515 |
Total | 20,859 | 11,110 |
| Year ended 31 December | ||
(US$ thousands except number of shares) | 2023 | 2022 |
| Numerator: | ||
Net (loss) for the year | (51,002) | (1,086) |
| Denominator: | ||
Weighted average number of ordinary shares for basic earnings/(loss) per share | 705,550,299 | 679,849,437 |
Adjustment for dilutive share options and RSUs | – | — |
Weighted average number of ordinary shares for diluted earnings/(loss) per share | 705,550,299 | 679,849,437 |
Basic earnings/(loss) per share (US$ cents) | (7.23) | (0.16) |
Diluted earnings/(loss) per share (US$ cents) | (7.23) | (0.16) |
| Year ended 31 December | ||
| Restated | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Carrying amount | ||
At the beginning of the year | 309,199 | — |
Acquisition of subsidiaries | – | 331,886 |
Finalisation of OpenFive PPA | – | (12,437) |
Increase in consideration for S338 election | – | 5,610 |
Reversal of deferred tax liability | – | (15,860) |
At the end of the year | 309,199 | 309,199 |
| Developed | Developed | Customer | RISC-V | Other | ||
| IP | technology | relationships | licences | intangibles | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | |
| Cost | ||||||
As at 1 January 2022 | 1,167 | — | — | — | — | 1,167 |
| Acquisition of subsidiaries | ||||||
(note 30) | 38,887 | 83,900 | 25,700 | 5,200 | 386 | 154,073 |
Additions | 4,343 | 4,255 | — | — | 3,747 | 12,345 |
Currency translation differences | (49) | — | — | — | — | (49) |
As at 31 December 2022 | 44,348 | 88,155 | 25,700 | 5,200 | 4,133 | 167,536 |
Additions | — | 54,539 | — | — | 1,825 | 56,364 |
| Re-classify to property | ||||||
and equipment | (1,162) | — | — | — | — | (1,162) |
Re-classification of intangibles | — | 2,947 | — | — | (2,947) | — |
Currency translation differences | — | — | — | — | — | — |
As at 31 December 2023 | 43,186 | 145,641 | 25,700 | 5,200 | 3,011 | 222,738 |
| Accumulated amortisation | ||||||
As at 1 January 2022 | — | — | — | — | — | — |
Amortisation charge for the year | 4,730 | — | 714 | 347 | 368 | 6,159 |
Currency translation differences | (29) | — | — | — | — | (29) |
As at 31 December 2022 | 4,701 | — | 714 | 347 | 368 | 6,130 |
Amortisation charge for the year | 10,112 | — | 2,142 | 1,040 | — | 13,294 |
Currency translation differences | — | — | — | — | — | — |
As at 31 December 2023 | 14,813 | — | 2,856 | 1,387 | 368 | 19,424 |
| Carrying amount | ||||||
As at 31 December 2022 | 39,647 | 88,155 | 24,986 | 4,853 | 3,765 | 161,406 |
As at 31 December 2023 | 28,373 | 146,441 | 22,844 | 3,813 | 1,843 | 203,314 |
| Computer | Furniture | Leasehold | Laboratory | ||
| equipment | and fixtures | improvements | equipment | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | |
| Cost | |||||
As at 1 January 2022 | 2,088 | 62 | 404 | — | 2,554 |
On acquisition of subsidiaries | 913 | 111 | 264 | 1,279 | 2,567 |
Additions | 10,128 | 286 | 1,261 | 93 | 11,768 |
Currency translation differences | (5) | (1) | (6) | — | (12) |
As at 31 December 2022 | 13,124 | 458 | 1,923 | 1,372 | 16,877 |
Acquisition of subsidiaries | — | — | — | — | — |
Additions | 8,488 | 824 | 2,349 | 6,907 | 18,568 |
Re-classify from intangible assets | — | — | — | 1,162 | 1,162 |
Currency translation differences | — | — | — | — | — |
As at 31 December 2023 | 21,612 | 1,282 | 4,272 | 9,441 | 36,607 |
| Accumulated depreciation | |||||
As at 1 January 2022 | 766 | 31 | 131 | — | 928 |
Depreciation charge for the year | 1,886 | 58 | 456 | 72 | 2,472 |
Currency translation differences | 16 | 9 | 31 | — | 56 |
As at 31 December 2022 | 2,668 | 98 | 618 | 72 | 3,456 |
Depreciation charge for the year | 8,921 | 259 | 810 | 1,222 | 11,212 |
Depreciation charged to the P&L then capitalised | — | — | — | 1,285 | 1,285 |
Currency translation differences | — | — | — | — | — |
As at 31 December 2023 | 11,589 | 357 | 1,428 | 2,579 | 15,953 |
| Carrying amount | |||||
As at 31 December 2022 | 10,456 | 360 | 1,305 | 1,300 | 13,421 |
As at 31 December 2023 | 10,023 | 925 | 2,844 | 6,862 | 20,654 |
| Buildings | Equipment | Total | |
| US$’000 | US$’000 | US$’000 | |
| Cost | |||
As at 1 January 2022 | 8,460 | 2,579 | 11,039 |
Acquisition of subsidiaries | 2,786 | — | 2,786 |
Additions | 4,308 | 3,023 | 7,331 |
Currency translation differences | (248) | (104) | (352) |
As at 31 December 2022 | 15,306 | 5,498 | 20,804 |
Additions | 5,265 | 608 | 5,873 |
Disposals | (551) | — | (551) |
Currency translation differences | (3) | — | (3) |
As at 31 December 2023 | 20,017 | 6,106 | 26,123 |
| Accumulated depreciation | |||
As at 1 January 2022 | 1,852 | 1,515 | 3,367 |
Depreciation charge for the year | 1,706 | 1,330 | 3,036 |
Currency translation differences | (90) | (62) | (152) |
As at 31 December 2022 | 3,468 | 2,783 | 6,251 |
Depreciation charge for the year | 3,006 | 1,606 | 4,612 |
Disposals | — | — | — |
Currency translation differences | (2) | — | (2) |
As at 31 December 2023 | 6,472 | 4,389 | 10,861 |
| Carrying amount | |||
As at 31 December 2022 | 11,838 | 2,715 | 14,553 |
As at 31 December 2023 | 13,545 | 1,717 | 15,262 |
| US$’000 | |
As at 1 January 2022 | 7,828 |
Acquisition of subsidiaries | 2,616 |
Additions | 7,196 |
Interest expense | 391 |
Lease payments | (3,038) |
Currency translation differences | (60) |
As at 31 December 2022 | 14,933 |
Additions | 5,385 |
Disposals | — |
Interest expense | 1,581 |
Lease payments | (4,740) |
Currency translation differences | (479) |
As at 31 December 2023 | 16,680 |
| As at 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Current | 3,953 | 3,756 |
Non-current | 12,727 | 11,177 |
Total lease liabilities | 16,680 | 14,933 |
| As at 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Expense relating to short-term leases and low-value lease expense | 716 | 1,769 |
Expense relating to variable lease payments not included in lease liabilities | — | 19 |
716 | 1,788 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Cash flow from financing activities | ||
Lease payments included in lease liabilities | 4,740 | 3,038 |
| Cash flow from operating activities | ||
Variable lease payments not included in lease liabilities | — | 19 |
Lease payments on short-term leases and leases of low-value assets | 716 | 1,769 |
Total cash outflow on lease payments | 5,456 | 4,826 |
| US$’000 | |
| Carrying amount | |
As at 1 January 2022 | 9,421 |
Additional investment | 9,060 |
Loss from joint venture | (18,481) |
As at 31 December 2022 | — |
Additional investment | 14,730 |
Loss from joint venture | (14,730) |
As at 31 December 2023 | – |
| As at 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Current assets | 23,766 | 18,536 |
Property and equipment | 5,043 | 1,908 |
Intangible assets | 53,774 | 71,331 |
Other non-current assets | 2,176 | 4,883 |
Current liabilities | 34,411 | 27,351 |
Non-current liabilities | 24,588 | 42,317 |
| Included in the above amounts are: | ||
Cash and cash equivalents | 13,700 | 15,729 |
Current financial liabilities (excluding trade payables) | – | — |
Non-current financial liabilities (excluding trade payables) | – | — |
Net assets (100%) | 25,759 | 26,990 |
Group share of net assets (42.5%) | 10,948 | 11,471 |
Share of losses of joint venture recognised as a liability | – | — |
Share of unrealised profits on IP licences to joint venture not recognised | 11,910 | 2,344 |
Carrying amount of liability in joint venture | – | — |
| As at 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Revenue | 19,826 | 5,517 |
Loss from continuing operations | (35,930) | (37,764) |
| Included in loss from continuing operations are: | ||
Depreciation and amortisation | (2 0,730) | (18,267) |
Interest expense | (2,171) | (2,936) |
Other comprehensive income | – | — |
Total comprehensive expense (100%) | (35,930) | (37,764) |
Group share of total comprehensive expense (42.5%) | (15,270) | (16,050) |
Reversal/(recognition) of share of unrealised profits on IP licences to joint venture | 540 | (2,431) |
Loss from joint venture | (14,730) | (18,481) |
| As at 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Cash at bank and in hand | 101,291 | 186,231 |
| As at 31 December | ||
| Restated | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Current | ||
Trade receivables from contracts with customers | 49,214 | 16,455 |
Less: Allowance for expected credit losses | (5,635) | (637) |
Trade receivables – net | 43,579 | 15,818 |
Restricted cash | 17,843 | 18,295 |
Other receivables | 16,667 | 13,030 |
Total current | 78,089 | 47,143 |
| Non-current | ||
Restricted cash | 6,392 | 18,793 |
Other receivables | – | 479 |
Total non-current | 6,392 | 19,272 |
Total trade and other receivables | 84,481 | 66,415 |
| As at 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Finished goods | 4,248 | 3,616 |
Work in progress | 5,737 | 10,413 |
Raw materials | 1,637 | 4,032 |
Total inventories | 11,622 | 18,061 |
| As at 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Current | ||
Prepayments | 17,094 | 70,601 |
Capitalised contract costs | 1,923 | 874 |
Total other assets | 19,017 | 71,475 |
| As at 31 December | ||
| Restated | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Current | ||
Trade payables | 18,098 | 23,573 |
Accrued expenses | 33,553 | 34,322 |
Social security and other taxes | 195 | 1,204 |
Contingent consideration | – | 5,000 |
Other payables | 17,439 | 24,566 |
Total current | 69,285 | 88,665 |
| Non-current | ||
Other payables | 1,775 | 10,555 |
Total non-current | 1,775 | 10,555 |
Total trade and other payables | 71,060 | 99,220 |
| As at 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Current | ||
Term Loan | 5,625 | 5,000 |
| Non-current | ||
Revolving Credit Facility | 125,000 | 110,000 |
Term Loan | 88,125 | 93,750 |
Israel Innovation Authority | 1,625 | 1,451 |
Total loans and borrowings | 220,375 | 210,201 |
| Loans and | Interest | Lease | ||
| borrowings | payable | liabilities | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | |
As at 1 January 2022 | — | — | 7,828 | 7,828 |
Acquisition of subsidiaries | 1,451 | — | 2,616 | 4,067 |
Financing cash inflow/(outflow) | 208,750 | (650) | (3,038) | 205,062 |
Currency translation differences | — | — | (60) | (60) |
Other movements | — | 3,134 | 7,587 | 10,721 |
As at 31 December 2022 | 210,201 | 2,484 | 14,933 | 227,618 |
Financing cash inflow/(outflow) | 10,000 | (18,390) | (4,740) | (13,130) |
Currency translation differences | 174 | — | (40) | 134 |
Other movements | — | 16,053 | 6,527 | 22,580 |
As at 31 December 2023 | 220,375 | 147 | 16,680 | 237,202 |
| As at 31 December 2023 | ||
| Carrying amount | ||
| Amortised | Fair | |
| cost | value | |
| US$’000 | US$’000 | |
| Financial assets | ||
Cash and cash equivalents | 101,291 | 101,291 |
Trade and other receivables | 103,498 | 103,498 |
Contract assets | 65,173 | 65,173 |
Total financial assets | 269,962 | 269,962 |
| Financial liabilities | ||
Trade and other payables | (71,060) | (71,060) |
Lease liabilities | (16,680) | (16,680) |
Loans and borrowings | (220,375) | (220,375) |
Total financial liabilities | (308,115) | (308,115) |
| Restated as at 31 December 2022 | ||||
| Carrying amount | ||||
| At fair value | ||||
| Amortised | through | Fair | ||
| cost | profit or loss | Total | value | |
| US$’000 | US$’000 | US$’000 | US$’000 | |
| Financial assets | ||||
Cash and cash equivalents | 186,231 | — | 186,231 | 186,231 |
Trade and other receivables | 137,890 | — | 137, 890 | 137, 8 90 |
Contract assets | 56,987 | — | 56,987 | 56,987 |
Total financial assets | 381,108 | — | 381,108 | 381,108 |
| Financial liabilities | ||||
Trade and other payables | (94,220) | (5,000) | (99,220) | (99,220) |
Lease liabilities | (14,933) | — | (14,933) | (14,933) |
Loans and borrowings | (210,201) | — | (210,201) | (210,201) |
Total financial liabilities | (319,354) | (5,000) | (324,354) | (324,354) |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Contingent consideration | ||
At the beginning of the year | (5,000) | — |
Acquisition of Precise-ITC | — | (740) |
Change in estimate (other operating expenses) | — | (4,260) |
Settlements | 5,000 | — |
At the end of the year | — | (5,000) |
As at 31 December 2023 | As at 31 December 2022 | |||||
| Weighted- | Gross carrying | Loss | Weighted- | Gross carrying | Loss | |
| average | amount | allowance | average | amount | allowance | |
| loss rate | US$’000 | $’000 | loss rate | US$’000 | $’000 | |
Start-up company based in developing country | 12% | 45,311 | 5,620 | 1% | 25,300 | 300 |
Other start-up companies | 0% | 21,658 | 85 | 6% | 21,500 | 1,194 |
| Established company based | ||||||
in developing country | 25% | 11,261 | 2,772 | 2% | 8,200 | 200 |
| Other established companies | 3% | 40,019 | 1,020 | 2% | 19,989 | 490 |
118,249 | 9,497 | 74,989 | 2,184 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
At the beginning of the year | 2,184 | — |
Net remeasurement of loss allowance | 7,337 | 2,184 |
Foreign exchange difference | (24) | — |
At the end of the year | 9,497 | 2,184 |
| As at 31 December 2023 | ||||
| Interest bearing | Non-interest | |||
| Floating rate | Fixed rate | bearing | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | |
Cash and cash equivalents | 65,443 | 1,457 | 34,391 | 101,291 |
Trade and other receivables and other assets | – | – | 103,498 | 103,498 |
Contract assets | – | – | 65,173 | 65,173 |
Total financial assets | 65,443 | 1,457 | 203,062 | 269,962 |
Trade and other payables | – | – | (71,060) | (71,060) |
Lease liabilities | – | – | (16,680) | (16,680) |
Loans and borrowings | (220,375) | – | – | (220,375) |
Total financial liabilities | (220,375) | – | (87,740) | (308,115) |
| Restated as at 31 December 2022 | ||||
| Interest bearing | Non-interest | |||
| Floating rate | Fixed rate | bearing | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | |
Cash and cash equivalents | 113,616 | 29,244 | 43,371 | 186,231 |
Trade and other receivables and other assets | – | – | 137,890 | 137,890 |
Contract assets | – | – | 56,987 | 56,987 |
Total financial assets | 113,616 | 29,244 | 238,248 | 381,108 |
Trade and other payables | – | – | (99,220) | (99,220) |
Lease liabilities | – | – | (14,933) | (14,933) |
Loans and borrowings | (210,201) | – | – | (210,201) |
Total financial liabilities | (210,201) | – | (114,153) | (324,354) |
| As at 31 December 2023 | ||||||||
| CAD | GBP | ILS | INR | RMB | TWD | USD | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | |
| Cash and cash | ||||||||
equivalents | 632 | 41,957 | 133 | 473 | 2,756 | 210 | 55,130 | 101,291 |
Trade and other receivables and other assets | 20,376 | 902 | 596 | 1,055 | 6,211 | 72 | 74,286 | 103,498 |
Contract assets | — | — | — | — | 66 | — | 65,107 | 65,173 |
Trade and other payables | (26,829) | (4,969) | (2,266) | (3,954) | (393) | (21) | (32,628) | (71,060) |
Lease liabilities | (14,949) | — | (832) | (890) | (9) | — | — | (16,680) |
Loans and borrowings | — | — | (1,625) | — | — | — | (218,750) | (220,375) |
(20,770) | 37,890 | (3,994) | (3,316) | 8,631 | 261 | (56,855) | (38,153) |
| Restated as at 31 December 2022 | |||||||
| CAD | GBP | ILS | INR | RMB | USD | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | |
| Cash and cash | |||||||
equivalents | (6,648) | 125,218 | 833 | 1,965 | 12,986 | 51,877 | 186,231 |
Trade and other receivables and other assets | — | — | — | 1,572 | 23 | 136,295 | 137,890 |
Contract assets | — | — | — | — | — | 56,987 | 56,987 |
Trade and other payables | (1,663) | (952) | (794) | (2,660) | (10,039) | (83,112) | (99,220) |
Lease liabilities | (12,579) | — | (1,049) | (1,305) | — | — | (14,933) |
Loans and borrowings | — | — | (1,451) | — | — | (208,750) | (210,201) |
(20,890) | 124,266 | (2,461) | (428) | 2,970 | (46,703) | 56,754 |
| As at 31 December | ||
| 2023 | 2022 | |
| Foreign currency | US$’000 | US$’000 |
CAD | 834/(834) | 4,807/(4,807) |
GBP | 778/(778) | 583/(583) |
ILS | 498/(498) | 18/(18) |
INR | 26/(26) | 187/(187) |
RMB | 632/(632) | 90/(90) |
USD | 899/(899) | 4,599/(4,599) |
| As at 31 December 2023 | ||||
| Due within | Due between | Due > | ||
| 1 year | 1 and 5 years | 5 years | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | |
Trade and other payables | 69,285 | 1,775 | – | 71,060 |
Lease liabilities | 3,953 | 7,660 | 5,067 | 16,680 |
Loans and borrowings | 5,625 | 214,750 | – | 220,375 |
78,863 | 224,185 | 5,067 | 308,115 |
| Restated as at 31 December 2022 | ||||
| Due within | Due between | Due > | ||
| 1 year | 1 and 5 years | 5 years | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | |
Trade and other payables | 88,665 | 10,555 | — | 99,220 |
Lease liabilities | 3,756 | 8,819 | 2,358 | 14,933 |
Loans and borrowings | 5,000 | 205,201 | — | 210,201 |
97,421 | 224,575 | 2,358 | 324,354 |
| As at 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Total equity | 467,908 | 468,273 |
Loans and borrowings | 220,375 | 210,201 |
Cash and cash equivalents | (101,291) | (186,231) |
Net debt | 119,084 | 23,970 |
Lease liabilities | 16,680 | 14,933 |
Total capital | 332,144 | 429,370 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
At the beginning of the year | 821 | — |
Acquisition of Open Silicon (note 30) | — | 323 |
| Recognised in profit or loss: | ||
Current service cost | 489 | 507 |
Interest expense | 60 | — |
| Recognised in other comprehensive income: | ||
Experience adjustments | 472 | — |
Change in financial assumptions | 735 | — |
Benefits paid by employer | (59) | (9) |
Currency translation differences | (42) | — |
At the end of the year | 2,476 | 821 |
Staff attrition rate - age less than 30 years | 10.0% p.a. |
Staff attrition rate - 31-44 years | 5% p.a. |
Staff attrition rate - 45 years and above | 3% p.a. |
Mortality rate | IALM 2012-14 |
Rate of increase in salaries year 1 | 22.0% p.a. |
Rate of increase in salaries year 2 | 15% p.a. |
Rate of increase in salaries year 3 onwards | 10% p.a. |
Discount rate | 7.4% p.a. |
| Number | Nominal value | |
| of shares | US$’000 | |
As at 1 January 2022 | 664,965,934 | 9,399 |
Shares issued under employee share schemes | 30,102,266 | 352 |
As at 31 December 2022 | 695,068,200 | 9,751 |
Shares issued under employee share schemes | 20,446,367 | 260 |
As at 31 December 2023 | 715,514,567 | 10,011 |
Year ended 31 December 2023 | Year ended 31 December 2022 | |||
| Number | Weighted-average | Number | Weighted-average | |
| of awards | exercise price (US$) | of awards | exercise price (US$) | |
Outstanding at the beginning of the year | 85,692,153 | 0.712 | 95,273,220 | 0.280 |
Granted | 24,810,455 | 1.387 | 23,109,685 | 1.640 |
Exercised or vested | (20,446,367) | 0.808 | (30,102,266) | 0.102 |
Forfeited | (3,792,278) | 1.002 | (2,588,486) | 1.381 |
Outstanding at the end of the year | 86,263,963 | 0.842 | 85,692,153 | 0.712 |
Vested at the end of the year | 43,669,961 | 0.339 | 41,720,539 | 0.221 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Payable: | ||
Within one year | 32,602 | 26,065 |
Between one and two years | 11,132 | 26,792 |
Between two and five years | 1,369 | 158 |
After more than five years | — | — |
Total | 45,103 | 53,015 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Short-term employee benefits | 5,898 | 5,962 |
Post-employment benefits | 481 | 59 |
Termination benefits | 25 | — |
Share-based payments | 4,774 | 2,208 |
11,178 | 8,229 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Transactions | ||
| Revenue from companies on which a Director is the chairman of the board | 429 | 3,549 |
Revenue from VeriSilicon | – | 3,270 |
Revenue from WiseWave, a joint venture, where there is common directorship | 66,879 | 58,207 |
Operating expenses from a company on which a Director is a director | (133) | — |
Costs capitalised as intangible assets from a company on which a Director is a director | (1,000) | (1,200) |
66,175 | 63,826 |
| Year ended 31 December | ||
| 2023 | 2022 | |
| US$’000 | US$’000 | |
| Balances | ||
| Accounts receivable from a company on which a Director is the chairman of the board | 1,650 | 350 |
Accounts receivable from VeriSilicon | – | 669 |
Accounts receivable from WiseWave, a joint venture, where there is common directorship | 6,364 | 3,360 |
Contract asset from companies on which a Director is the chairman of the board 1 | 2,567 | 6,750 |
Contract asset from WiseWave, a joint venture, where there is common directorship | 40,785 | 20,217 |
Accrued liabilities with a company on which a Director is a director | (600) | (600) |
50,766 | 30,746 | |
Contract liabilities from a company on which a Director is the chairman of the board | – | 686 |
Prepaid expenses with a company in which a Director is a director | (67) | — |
(67) | 686 |
| Precise-ITC | OpenFive | Banias Labs | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | |
| Assets acquired | ||||
Cash and cash equivalents | 803 | 14,503 | 9,131 | 24,437 |
Trade and other receivables | 269 | 38,451 | 1,256 | 39,976 |
Inventories | — | 14,671 | — | 14,671 |
Technology/IP | 7,800 | 30,100 | 83,900 | 121,800 |
Customer relationships | — | 25,700 | — | 25,700 |
Other intangibles | — | 6,573 | — | 6,573 |
Intangible assets | 7,800 | 62,373 | 83,900 | 154,073 |
Property and equipment | 52 | 813 | 1,702 | 2,567 |
Other assets | — | 1,667 | 1,119 | 2,786 |
Total assets acquired | 8,924 | 132,478 | 97,108 | 238,510 |
| Liabilities assumed | ||||
Trade and other payables | (70) | (40,924) | (2,073) | (43,067) |
Contract liabilities | (1,120) | (40,241) | — | (41,361) |
Deferred tax liabilities | (1,621) | — | (13,613) | (15,234) |
Other liabilities | — | (1,538) | (5,261) | (6,799) |
Total liabilities | (2,811) | (82,703) | (20,947) | (106,461) |
Net identifiable assets acquired | 6,113 | 49,775 | 76,161 | 132,049 |
Goodwill arising on acquisition | 3,097 | 159,471 | 146,585 | 309,153 |
Consideration | 9,210 | 209,246 | 222,746 | 441,202 |
| Purchase consideration was as follows: | ||||
Cash paid on completion | 8,470 | 203,636 | 222,746 | 434,852 |
Purchase price adjustment | — | 5,610 | — | 5,610 |
Contingent consideration | 740 | — | — | 740 |
Consideration | 9,210 | 209,246 | 222,746 | 441,202 |
| 2023 | 2022 | |
| US$’000 | US$’000 | |
Cash paid on completion | — | 434,852 |
Purchase price adjustment | 5,610 | — |
Contingent consideration | 740 | — |
Consideration paid | 6,350 | 434,852 |
Cash and cash equivalents acquired | — | (24,437) |
Cash outflow on purchase of businesses, net of cash acquired | 6,350 | 410,415 |